Payment overview · 2025
General Payments
$58.06
3 reported records · 2 companies
Healthcare provider profile · identity verified
Edward L White, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · MOUNTAIN HOME, AR · NPI 1144294992
Verified facts
What the public records show
CMS Open Payments records show Edward L White, M.D. received $58.06 in general payments during 2025 across 3 reported records.
PFIZER INC. accounted for 51.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis, Nurtec Odt.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 159 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NURTEC ODT as an associated drug or biological on 217574 records involving 54025 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Nurtec Odt by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $30.13 | 51.9% | 2 | 2025 |
| Regeneron Healthcare Solutions, Inc. | Unresolved — no canonical attribution shown | $27.93 | 48.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $58.06 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| DUPIXENT Normalized: dupixent |
Biological | Regeneron Healthcare Solutions, Inc. | $27.93 | 1 | 2025 |
Source payment records
|
|||||
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $16.15 | 1 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $16.15 | 1 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $16.15 | 1 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $13.98 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $13.98 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 159 | exact normalized | Medicare Part D |
| NURTEC ODT nurtec odt |
2025 | Nurtec Odt | 2024 | 17 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
159 | 37 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | NURTEC ODT open payments reported associated product |
CMS Open Payments — General Payments 217574 supporting records · 54025 recipient NPIs · example record 1228794063 |
Nurtec Odt · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 630 | 148 |
| Levothyroxine Sodium | Levothyroxine Sodium | 602 | 145 |
| Lisinopril | Lisinopril | 422 | 115 |
| Losartan Potassium | Losartan Potassium | 416 | 105 |
| Pantoprazole Sodium | Pantoprazole Sodium | 406 | 92 |
| Alprazolam | Alprazolam | 361 | 62 |
| Amlodipine Besylate | Amlodipine Besylate | 354 | 93 |
| Gabapentin | Gabapentin | 296 | 71 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 272 | 53 |
| Trazodone Hcl | Trazodone Hcl | 267 | 57 |
| Hydrochlorothiazide | Hydrochlorothiazide | 242 | 66 |
| Atenolol | Atenolol | 236 | 61 |
| Omeprazole | Omeprazole | 231 | 61 |
| Alendronate Sodium | Alendronate Sodium | 229 | 59 |
| Metoprolol Tartrate | Metoprolol Tartrate | 223 | 61 |
| Furosemide | Furosemide | 222 | 52 |
| Metformin Hcl | Metformin Hcl | 203 | 56 |
| Tramadol Hcl | Tramadol Hcl | 190 | 29 |
| Escitalopram Oxalate | Escitalopram Oxalate | 184 | 48 |
| Metoprolol Succinate | Metoprolol Succinate | 181 | 47 |
| Tamsulosin Hcl | Tamsulosin Hcl | 180 | 52 |
| Potassium Chloride | Potassium Chloride | 165 | 37 |
| Prednisone | Prednisone | 164 | 82 |
| Eliquis | Apixaban | 159 | 37 |
| Duloxetine Hcl | Duloxetine Hcl | 150 | 30 |
| Simvastatin | Simvastatin | 150 | 36 |
| Glimepiride | Glimepiride | 149 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 145 | 39 |
| Sertraline Hcl | Sertraline Hcl | 139 | 34 |
| Metformin Hcl Er | Metformin Hcl | 133 | 38 |
| Tizanidine Hcl | Tizanidine Hcl | 133 | 40 |
| Zolpidem Tartrate | Zolpidem Tartrate | 133 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 132 | 31 |
| Carvedilol | Carvedilol | 130 | 28 |
| Meloxicam | Meloxicam | 129 | 36 |
| Pravastatin Sodium | Pravastatin Sodium | 127 | 32 |
| Clonazepam | Clonazepam | 126 | 20 |
| Famotidine | Famotidine | 125 | 33 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 125 | 25 |
| Pioglitazone Hcl | Pioglitazone Hcl | 124 | 31 |
| Mirtazapine | Mirtazapine | 120 | 28 |
| Ozempic | Semaglutide | 114 | 19 |
| Allopurinol | Allopurinol | 108 | 27 |
| Nortriptyline Hcl | Nortriptyline Hcl | 106 | 24 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 105 | 33 |
| Montelukast Sodium | Montelukast Sodium | 99 | 26 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 98 | 29 |
| Fluoxetine Hcl | Fluoxetine Hcl | 96 | 24 |
| Warfarin Sodium | Warfarin Sodium | 94 | 21 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 92 | 16 |
| Donepezil Hcl | Donepezil Hcl | 88 | 27 |
| Lorazepam | Lorazepam | 86 | 20 |
| Propranolol Hcl | Propranolol Hcl | 79 | 17 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 75 | 16 |
| Doxycycline Hyclate | Doxycycline Hyclate | 71 | 58 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 71 | 19 |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 68 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 66 | 41 |
| Buspirone Hcl | Buspirone Hcl | 65 | 17 |
| Estradiol | Estradiol | 63 | 15 |
| Colestipol Hcl | Colestipol Hcl | 61 | 12 |
| Bupropion Hcl | Bupropion Hcl | 59 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 59 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 59 | 14 |
| Diazepam | Diazepam | 58 | 15 |
| Acyclovir | Acyclovir | 57 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 56 | 17 |
| Jardiance | Empagliflozin | 54 | 13 |
| Ondansetron Odt | Ondansetron | 54 | 13 |
| Spironolactone | Spironolactone | 54 | 12 |
| Lansoprazole | Lansoprazole | 49 | suppressed |
| Primidone | Primidone | 49 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 45 | suppressed |
| Celecoxib | Celecoxib | 45 | 13 |
| Ezetimibe | Ezetimibe | 45 | 12 |
| Digoxin | Digoxin | 44 | suppressed |
| Lovastatin | Lovastatin | 43 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 42 | suppressed |
| Temazepam | Temazepam | 42 | 11 |
| Solifenacin Succinate | Solifenacin Succinate | 41 | 12 |
| Synthroid | Levothyroxine Sodium | 41 | 13 |
| Tresiba Flextouch U-200 | Insulin Degludec | 41 | suppressed |
| Bumetanide | Bumetanide | 39 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 39 | 11 |
| Topiramate | Topiramate | 39 | suppressed |
| Glipizide | Glipizide | 38 | suppressed |
| Bupropion Xl | Bupropion Hcl | 37 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 37 | suppressed |
| Methotrexate | Methotrexate Sodium | 37 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 37 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 37 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 35 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 35 | 11 |
| Myrbetriq | Mirabegron | 35 | suppressed |
| Nifedipine Er | Nifedipine | 35 | 11 |
| Clonidine Hcl | Clonidine Hcl | 34 | 13 |
| Fluconazole | Fluconazole | 34 | 19 |
| Xarelto | Rivaroxaban | 34 | suppressed |
| Cefdinir | Cefdinir | 33 | 30 |
| Memantine Hcl | Memantine Hcl | 33 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 32 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 32 | 13 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 30 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 29 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 29 | suppressed |
| Sucralfate | Sucralfate | 28 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 27 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 26 | suppressed |
| Nystatin | Nystatin | 26 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 25 | suppressed |
| Valsartan | Valsartan | 25 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 24 | suppressed |
| Nitroglycerin | Nitroglycerin | 24 | 18 |
| Diltiazem Hcl | Diltiazem Hcl | 22 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 22 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 22 | suppressed |
| Pregabalin | Pregabalin | 22 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 21 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 21 | suppressed |
| Olanzapine | Olanzapine | 21 | suppressed |
| Ranolazine Er | Ranolazine | 21 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 20 | suppressed |
| Gemfibrozil | Gemfibrozil | 20 | suppressed |
| Klor-Con M20 | Potassium Chloride | 20 | suppressed |
| Levetiracetam | Levetiracetam | 20 | suppressed |
| Amoxicillin | Amoxicillin | 19 | 16 |
| Calcitriol | Calcitriol | 19 | suppressed |
| Finasteride | Finasteride | 19 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 19 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 18 | suppressed |
| Carisoprodol | Carisoprodol | 18 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 17 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 17 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Irbesartan | Irbesartan | 16 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 16 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | 13 |
| Mupirocin | Mupirocin | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Ramipril | Ramipril | 14 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 13 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 13 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 13 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 13 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 13 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 12 | suppressed |
| Dextroamphetamine Sulfate Er | Dextroamphetamine Sulfate | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 12 | suppressed |
| Naproxen | Naproxen | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Repatha Sureclick | Evolocumab | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Humalog | Insulin Lispro | 11 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Januvia | Sitagliptin Phosphate | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Methocarbamol | Methocarbamol | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Progesterone | Progesterone, Micronized | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
| Xeljanz Xr | Tofacitinib Citrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $58.06 · 3 records | PFIZER INC. | ABRYSVO, COMIRNATY, DUPIXENT, ELIQUIS, NURTEC ODT, PREVNAR 20 | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error